文献速递慢性肾脏病遗传性与小管间质肾病

肌成纤维细胞清除可减少常染色体显性多囊肾病小鼠的肾囊肿生长与纤维化

Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
PubMed 文献 · Kidney Int · 2022-10-20

研究在Pkd1RC/RC小鼠模型中利用更昔洛韦-胸苷激酶系统选择性清除表达α-平滑肌肌动蛋白的肌成纤维细胞,发现清除肌成纤维细胞可减少肾纤维化、保留肾功能并显著减少囊肿生长和囊上皮细胞增殖;体外实验显示ADPKD患者肾脏肌成纤维细胞共培养及条件培养基可促进人ADPKD囊上皮细胞微囊肿生长和增殖,条件培养基中PAI1、TIMP1和2、NGAL、TFPI-2等蛋白酶抑制剂水平高,重组PAI1和TIMP1可增加囊上皮细胞增殖。

要点

  • 在Pkd1RC/RC小鼠中清除α-SMA阳性肌成纤维细胞可减少肾纤维化并保留肾功能。
  • 肌成纤维细胞清除显著减少RC/RC;αSMAtk小鼠肾脏的囊肿生长和囊上皮细胞增殖。
  • ADPKD患者肾脏肌成纤维细胞条件培养基可促进囊上皮细胞微囊肿生长和增殖。

核心结论

  • 肌成纤维细胞直接促进ADPKD肾脏的囊上皮细胞增殖、囊肿生长和纤维化,靶向肌成纤维细胞可能成为治疗多囊肾病的新策略。

研究设计与样本

  • 在Pkd1RC/RC(RC/RC)小鼠模型中使用更昔洛韦-胸苷激酶系统选择性清除表达α-平滑肌肌动蛋白的肌成纤维细胞,生成RC/RC;αSMAtk小鼠。
  • 更昔洛韦治疗4周后评估肌成纤维细胞清除对肾纤维化、肾功能、囊肿生长和囊上皮细胞增殖的影响,并以野生型和RC/RC同窝小鼠作对照。
  • 体外共培养ADPKD患者肾脏肌成纤维细胞与人ADPKD囊上皮细胞,并用人ADPKD肾脏肌成纤维细胞条件培养基及重组PAI1、TIMP1处理囊上皮细胞。

主要发现

  • 更昔洛韦治疗4周清除肌成纤维细胞,减少RC/RC;αSMAtk小鼠肾脏纤维化并保留肾功能。
  • 肌成纤维细胞清除显著减少RC/RC;αSMAtk小鼠肾脏的囊肿生长和囊上皮细胞增殖。
  • 相同更昔洛韦治疗未改变野生型或RC/RC同窝小鼠的囊肿生长或纤维化。
  • 体外与ADPKD患者肾脏肌成纤维细胞共培养增加人ADPKD囊上皮细胞3D微囊肿生长。
  • ADPKD肾脏肌成纤维细胞条件培养基增加囊上皮细胞微囊肿生长和细胞增殖,其中PAI1、TIMP1和2、NGAL、TFPI-2等蛋白酶抑制剂水平高,重组PAI1和TIMP1增加囊上皮细胞增殖。

临床怎么用

  • 原文结论认为靶向肌成纤维细胞可能是治疗多囊肾病的新策略,未给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autosomal dominant polycystic kidney disease (ADPKD) involves the development and persistent growth of fluid filled kidney cysts. In a recent study, we showed that ADPKD kidney cyst epithelial cells can stimulate the proliferation and differentiation of peri-cystic myofibroblasts. Although dense myofibroblast populations are often found surrounding kidney cysts, their role in cyst enlargement or fibrosis in ADPKD is unclear. To clarify this, we examined the effect of myofibroblast depletion in the Pkd1RC/RC (RC/RC) mouse model of ADPKD. RC/RC;αSMAtk mice that use the ganciclovir-thymidine kinase system to selectively deplete α-smooth muscle actin expressing myofibroblasts were generated. Ganciclovir treatment for four weeks depleted myofibroblasts, reduced kidney fibrosis and preserved kidney function in these mice. Importantly, myofibroblast depletion significantly reduced cyst growth and cyst epithelial cell proliferation in RC/RC;αSMAtk mouse kidneys. Similar ganciclovir treatment did not alter cyst growth or fibrosis in wild-type or RC/RC littermates. In vitro, co-culture with myofibroblasts from the kidneys of patients with ADPKD increased 3D microcyst growth of human ADPKD cyst epithelial cells. Treatment with conditioned culture media from ADPKD kidney myofibroblasts increased microcyst growth and cell proliferation of ADPKD cyst epithelial cells. Further examination of ADPKD myofibroblast conditioned media showed high levels of protease inhibitors including PAI1, TIMP1 and 2, NGAL and TFPI-2, and treatment with recombinant PAI1 and TIMP1 increased ADPKD cyst epithelial cell proliferation in vitro. Thus, our findings show that myofibroblasts directly promote cyst epithelial cell proliferation, cyst growth and fibrosis in ADPKD kidneys, and their targeting could be a novel therapeutic strategy to treat PKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Dwivedi N, Jamadar A, Mathew S, et al. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease. Kidney Int. 2022. PMID: 36273656. doi:10.1016/j.kint.2022.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。